PURE Bioscience, Inc. Convertible Notes Payable
PURE Bioscience, Inc. (PURE) had Convertible Notes Payable of $5.77 million as of 2026-04-30, per its 10-Q filed 2026-06-15.
Financial Statements › Balance Sheet › Liabilities › Notes Payable
us-gaap:ConvertibleNotesPayable · last filed 2026-06-15
- 2026-04-30: Convertible Notes Payable $5.77M.
- 2026-01-31: Convertible Notes Payable $5.52M.
- 2025-10-31: Convertible Notes Payable $5.15M.
- 2025-07-31: Convertible Notes Payable $4.80M.
| Period end | Convertible Notes Payable |
|---|---|
| 2026-04-30 | $5.77M 10-Q · filed 2026-06-15 |
| 2026-01-31 | $5.52M 10-Q · filed 2026-03-17 |
| 2025-10-31 | $5.15M 10-Q · filed 2025-12-15 |
| 2025-07-31 | $4.80M 10-Q · filed 2026-06-15 |
| 2024-07-31 | $2.80M 10-K · filed 2025-10-29 |